Experimental Autoimmune Encephalomyelitis

Experimental autoimmune encephalomyelitis is a commonly used animal model for autoimmune central nervous system diseases, most notably multiple sclerosis. Here is the latest research on experimental autoimmune encephalomyelitis.

December 29, 2020

Suppression of Experimental Autoimmune Encephalomyelitis by ILT3.Fc

The Journal of Immunology : Official Journal of the American Association of Immunologists
Zheng XuNicole Suciu-Foca
December 21, 2020
Open Access

Thyroid hormone and thyromimetics inhibit myelin and axonal degeneration and oligodendrocyte loss in EAE

BioRxiv : the Preprint Server for Biology
P ChaudharyD N Bourdette
January 1, 2021

Mesenchymal stem cells instruct a beneficial phenotype in reactive astrocytes

Tiziana VigoAntonio Uccelli
December 29, 2020

Alleviation of extensive visual pathway dysfunction by a remyelinating drug in a chronic mouse model of multiple sclerosis

Brain Pathology
Maria T SekyiSeema K Tiwari-Woodruff
January 11, 2021
Open Access

Thyroid hormone and thyromimetics inhibit myelin and axonal degeneration and oligodendrocyte loss in EAE

Journal of Neuroimmunology
P ChaudharyD N Bourdette
January 14, 2021
Open Access

CCR6 blockade on regulatory T cells ameliorates experimental model of multiple sclerosis

Central-European Journal of Immunology
Izabela Jatczak-PawlikAndrzej Glabinski
December 30, 2020

Cell type-specific transcriptomics identifies neddylation as a novel therapeutic target in multiple sclerosis

Brain : a Journal of Neurology
Kicheol KimSergio E Baranzini
January 8, 2021

Thrombin generation and activity in multiple sclerosis

Metabolic Brain Disease
Kelley R JordanNorah G Verbout
December 29, 2020

Toll-like receptor 2 and 4 antagonism for the treatment of experimental autoimmune encephalitis (EAE)-related pain

Brain, Behavior, and Immunity
Andrew J KwilaszLinda R Watkins
January 4, 2021

The Potential for Immunospecific Therapy in Multiple Sclerosis Based on Identification of Driver Clones of the Disease

Critical Reviews in Immunology
Claudia Raja GabagliaTodd A Braciak
January 8, 2021

Aryl Hydrocarbon Receptor Activation in Astrocytes by Laquinimod Ameliorates Autoimmune Inflammation in the CNS

Neurology. Neuroimmunology and Neuroinflammation
Veit RothhammerFrancisco J Quintana
January 7, 2021
Open Access

Dopaminergic stimulation leads B-cell infiltration into the central nervous system upon autoimmunity

Carolina PradoRodrigo Pacheco
January 12, 2021
Open Access

Differential modulation of Ahr and Arid5a: A promising therapeutic strategy for autoimmune encephalomyelitis

Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society
Abdullah Alzahrani, Hamza Hanieh

Sign up to follow this feed and discover related papers.

Related Feeds

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Acute Hemorrhagic Leukoencephalitis

Acute hemorrhagic leukoencephalitis is a rare form of acute disseminated encephalomyelitis characterized by acute inflammation in the brain and spinal cord that causes demyelination and bleeding. It is often fatal, although treatment with immunosuppressives and plasma exchange can be helpful. Find the latest research on acute hemorrhagic leukoencephalitis here.

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.

Adult-Onset Still's Disease

Adult-onset Still's disease (AOSD) is a form of Still's disease, a rare systemic autoinflammatory disease characterized by the classic triad of persistent high spiking fevers, joint pain, and a distinctive salmon-colored bumpy rash. Discover the latest research on AOSD here.

Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis is a form of of brain inflammation due to antibodies against NMDA receptors. Discover the latest research on anti-NMDA receptor encephalitis here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autoimmune Disease Therapy

In autoimmune diseases, the immune system responds and attacks self-antigens and damages or impairs the function of the tissues. The treatment for autoimmune diseases often involves immunosuppressive agents, but newer treatments are being investigated. Discover the latest research on autoimmune disease therapy here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia (AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. Discover the latest research on AIHA here.

© 2021 Meta ULC. All rights reserved